This inventor holds 1 USPTO granted patent. Top assignees: Banyu Pharmaceutical Co. Ltd, Merck Sharp + Dohme Corp.. Active years: 2011.
Company Filing History:
1 out of 237 
1 out of 2,405 
Years Active: 2011
Title: The Innovative Contributions of Mary M Kim
Introduction
Mary M Kim is a notable inventor based in Cheltenham, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for Type 2 diabetes. Her innovative work has led to the creation of a patented process that enhances the synthesis of important medicinal compounds.
Latest Patents
Mary M Kim holds a patent for a process titled "Process for preparing chiral dipeptidyl peptidase-IV inhibitor intermediates." This novel process facilitates the preparation of chiral trans-2,3-disubstituted 5-oxotetrahydropyrans, which are crucial in synthesizing dipeptidyl peptidase-IV inhibitors. These inhibitors play a vital role in the treatment of Type 2 diabetes. The patent highlights the structural formula of the compounds and the utility of the intermediates obtained from the process. She has 1 patent to her name.
Career Highlights
Throughout her career, Mary has worked with prominent companies in the pharmaceutical industry. Notably, she has been associated with Merck Sharp & Dohme Corp. and Banyu Pharmaceutical Co. Ltd. Her experience in these organizations has contributed to her expertise in drug development and innovation.
Collaborations
Mary M Kim has collaborated with esteemed colleagues, including Jonathan D Rosen and Michael J Zacuto. These partnerships have further enriched her research and development efforts in the pharmaceutical sector.
Conclusion
Mary M Kim's contributions to the field of pharmaceuticals, particularly in diabetes treatment, showcase her innovative spirit and dedication to improving healthcare. Her patented process represents a significant advancement in the synthesis of vital medicinal compounds.